News
Attorneys
Practice Areas
Print PDF
3 Things To Watch After Sandoz's Biosimilars Win
March 20, 2015
Law360
Partner Andrew Ryan comments in Law360's March 20, 2015 article on Amgen Inc. v Sandoz Inc., "3 Things To Watch After Sandoz's Biosimilars Win."
Ryan is a litigator at Cantor Colburn and a member of the firm's Pharmaceutical Practice Group.
